In the current study, orthotopic mouse HCC xenografts were established and subsequent portal vein injection of anti‐GPC3 CAR‐T cells was employed to provide an alternative approach for CAR‐T cell infusion in clinical settings. Here, GPC3 is linked to hepatocellular carcinoma.